Skip to content
My WebMD Sign In, Sign Up
Secondary Progressive MS treatment fast-tracked for FDA Approval
avatar
hackwriter posted:
Opexa has changed the name of its drug, Tovaxin, to Tcelna, as it relaunches Phase IIb trials in 2012 in SPMS patients. See details in the link below:

http://www.opexatherapeutics.com/?page=tovaxin&section=tovaxin

Currently there is only one FDA-approved treatment for SPMS. Novantrone, originally a cancer chemotherapy, is an infusion therapy performed once every three months for up to 24 months for the treatment of Secondary-Progressive MS.
Was this Helpful?
2 of 2 found this helpful
Reply


Featuring Experts

Neil S. Lava, MD, is the director of the multiple sclerosis clinic at Emory University in Atlanta. He has been treating multiple sclerosis patients si...More

Health Insurance in Your State

Learn about plans, benefits, and costs in your state's Marketplace.

From WebMD

Helpful Tips

Help Our Community & Experts Help You - Please Read
Welcome to the WebMD Multiple Sclerosis Community! Please don't respond to this discussion. Instead, please read before you start your ... More
Was this Helpful?
105 of 107 found this helpful

Related Drug Reviews

  • Drug Name User Reviews

Report Problems to the
Food and Drug Administration

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.